Skip to main content
MSF logo
  • Media room
  • Contact
  • msf.org
  • MSF Access
    • About MSF Access
    • Media room
    • Latest news
    • Jobs
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Our work
    • Diabetes
    • Drug-resistant infections
    • Hypertension
    • Patents and intellectual property
      • Pandemic prevention, preparedness and response
      • The Patent Oppositions Database
    • Research and development
      • Spotlight on: the Big Pharma double-dip
      • Transparency Matters: Clinical Trials Costs
    • Tuberculosis
    • Vaccines
    • Other work
      • COVID-19
      • Hepatitis C
      • HIV/AIDS
      • Tropical and neglected diseases
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Get involved
    • Campaign success stories
      • #NoMoreTears Johnson & Johnson Can you hear us?
      • A Fair Shot
      • Novartis 'Drop the case'
      • Trans-pacific Partnership (TPP)
    • Recent campaigns
      • Time for $5
      • No Patents in a Pandemic
      • Share the Tech - Save Lives
    MSF Access Missions Medicines Should Not be a Luxury
    Take Action
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Resources
    • Press releases
    • Statements
    • Letters
    • Opinion articles
    • Feature stories
    • Interviews
    • Blog
    • Newsletters
    • Publications
    • Research articles
    • Topic overview pages
    • Videos
    • Photo stories
    • Infographics
    • Events
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Media room
  • Contact
  • msf.org
  • MSF Access
    • About MSF Access
    • Media room
    • Latest news
    • Jobs
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Our work
    • Diabetes
    • Drug-resistant infections
    • Hypertension
    • Patents and intellectual property
      • Pandemic prevention, preparedness and response
      • The Patent Oppositions Database
    • Research and development
      • Spotlight on: the Big Pharma double-dip
      • Transparency Matters: Clinical Trials Costs
    • Tuberculosis
    • Vaccines
    • Other work
      • COVID-19
      • Hepatitis C
      • HIV/AIDS
      • Tropical and neglected diseases
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Get involved
    • Campaign success stories
      • #NoMoreTears Johnson & Johnson Can you hear us?
      • A Fair Shot
      • Novartis 'Drop the case'
      • Trans-pacific Partnership (TPP)
    • Recent campaigns
      • Time for $5
      • No Patents in a Pandemic
      • Share the Tech - Save Lives
    MSF Access Missions Medicines Should Not be a Luxury
    Take Action
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Resources
    • Press releases
    • Statements
    • Letters
    • Opinion articles
    • Feature stories
    • Interviews
    • Blog
    • Newsletters
    • Publications
    • Research articles
    • Topic overview pages
    • Videos
    • Photo stories
    • Infographics
    • Events
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
Medicines shouldn’t be a luxury Take action
Get involved
Our campaigns

Latest Press Releases

Latest Press Releases

Gavi, the Vaccine Alliance, 20 year anniversary
Press release
Press release |
21 January 2020
Vaccines

As Gavi turns 20, MSF urges the vaccine alliance to protect more kids from pneumonia

4 min
•	MSF medical doctor, Stefanos Tsallas vaccinates a child from refugee camp against pneumonia
Press release
Press release |
20 December 2019
Vaccines

First alternative pneumonia vaccine breaks Pfizer and GSK’s decades-long stranglehold, promising more children protected against biggest childhood killer

4 min
The first batch of the Ad26.ZEBOV / MVA-BN-Filo vaccine, produced by Janssen / Johnson & Johnson, has arrived in Goma, Democratic Republic of Congo. The start of the study is scheduled for November 14th. Photograph by Gabriella Bianchi
Press release
Press release |
05 December 2019
Vaccines

MSF response to Gavi announcement on financing of global emergency stockpile of Ebola vaccine

3 min
The pneumonia vaccine from GSK used for vaccination in refugee camps in Greek islands was made available at a special reduced price of US$9 while its retail price is $168 in Greece. Photograph by Anna Pantelia
Press release
Press release |
02 December 2019
Vaccines

US$262 million subsidy should not go to pharma giants Pfizer and GSK for pneumococcal vaccine

5 min
20-year-old Bagat Adshar, testing his blood sugar level with a glucometer in MSF’s diabetes clinic in Agok hospital. Photo by Musa Mahad
Press release
Press release |
14 November 2019
Diabetes

MSF response to the World Health Organization’s launch of its ‘prequalification’ programme for insulin

3 min
"" Photograph by Sophia Apostolia
Press release
Press release |
31 October 2019
Tuberculosis

Protestors demand Cepheid halve the price of GeneXpert TB tests to US$5

6 min
MSF and TB activists disrupt opening of TB conference to protest drug corporations keeping life-saving medicines from people Copyright by Sophia Apostolia
Press release
Press release |
30 October 2019
Tuberculosis

MSF and TB activists disrupt opening of TB conference to protest drug corporations keeping life-saving medicines from people

10 min
S. Thangkhoshin Hookip is a MDR-TB patient in Churachandpur. Every day MSF nurses visit him to administer an injection and watch him take all the daily medicines he needs to take (15 pills in total). Photograph by Jan-Joseph Stok
Press release
Press release |
29 October 2019
Tuberculosis

Price announced for new lifesaving TB drug pretomanid still too high

3 min
  • Load More
Navigate
  • About MSF Access
  • Contact us
  • Get involved
  • Our work
  • Resources
  • Search
Get updates
  • Sign up for our newsletter
  • Privacy & data protection information
Contact

MSF Access
Médecins Sans Frontières
140 Route de Ferney
1202 Geneva, Switzerland
Phone:+41 22 849 8484
E-mail: [email protected]

Follow us

  • X
  • Facebook
  • YouTube
  • Medium
Medicines Shouldn't Be A Luxury